Oddifact

Executive Summary

Oddifact is an AI-driven biotechnology company leveraging its proprietary artificial intelligence platform to discover and develop new treatments for rare diseases. Founded in 2020 and headquartered in San Francisco, the company analyzes existing molecules and scientific data to identify therapeutic candidates. Its strategy focuses on creating regulatory-ready program packages that can be partnered with larger pharmaceutical firms for clinical development. By targeting rare diseases, Oddifact addresses significant unmet medical needs while benefiting from accelerated regulatory pathways and potential market exclusivity.

Upcoming Catalysts (preview)

• Q3 2026Partnership or licensing agreement with a biopharma company50% success
• Q2 2026Publication of preclinical validation data in a peer-reviewed journal70% success
• Q4 2026Series A funding round announcement40% success